German CureVac Vaccine Protocol, Success of Public and Private Collaboration | Tec Review
“…Clinical trials of the German Curevac vaccine carried out jointly by private institutions such as TecSalud and the Mexican government have set the pattern to follow: synergy between public and private is necessary.
Guillermo Torre, rector of TecSalud and vice president of Research at Tecnológico de Monterrey, agrees.
During the Research Rounds virtual forum, where advances in the Herald protocol for the Curevac vaccine were discussed, Torre explained that the way in which the current pandemic has been dealt with has put the importance of the health sector in Latin American countries under the scrutiny of public opinion…”